SINTEF Industry Biotechnology and Nanomedicine
RESEARCH, TECHNOLOGY AND INNOVATION
Biotechnology and nanomedicine are key enabling technologies for various sectors of society and multiple industries. The technology is used in development of pharmaceuticals, vaccines, biomaterials, enzymes, food, feed, chemicals and energy. SINTEF Industry has a strong operation in the fields of microbial molecular biology, bioprocess- and medical technology, biopolymers/polymers, biopharmaceuticals and nanomedicine, and is operating a state-of-the-art research infrastructure including advanced mass spectrometry.
High throughput screening facility, Trondheim
The robotic screening facility at SINTEF are optimized for high throughput analytical and cultivation work and enables us to process of thousands of samples or cultures per day.
Molecular biology laboratory
We have state of the art equipment for molecular biology, including an Illumina MiSeq sequencer, droplet digital PCR (ddPCR), Agilent Bioanalyzer, CHEF Mapper XA pulse field gel electrophoresis system and a Bluepippin cassette-based gel electrophoresis system for DNA and protein separation, in addition to ÄKTA FPLC equipment for protein purification. Our co-workers have several years of experience and master most topics and protocols related to genetic modification of bacteria.
Fermentation laboratory at SINTEF
SINTEF has a nationally leading research laboratory for development of microbial and cell based production processes. The laboratory has robotic equipment for miniaturized cultivation, large capacity incubators for shake flasks, laboratory fermentors (1-3 L) equipped for extensive process control and monitoring, and a pilot plant with two fermenters (50 and 300 L) for scale-up studies and small productions.
PlastiSea - Novel enhanced bioplastics from sustainable processing of seaweed
The main objective of PlastiSea is to develop novel bioplastic materials based on cultivated and wild species of brown algae.
Immuno – New Methods for cancer immunotherapy
The main goal of this project is to develop SINTEF’s competence within biotechnology and drug discovery/development to also include immunotherapies.
Mucoprotect – A novel generic system for targeted delivery of oral vaccines
Vaccines are by far the most important tool in preventing disease in Norwegian aquaculture. Without the systematic use of efficient vaccines industrialisied fish farming would be an impossibility. Despite this, 53 million salmon were lost in Norway in 2017 due to illness and injury, also related to salmon lice treatment. In the project we will develop novel, clever vaccines based on nanoparticles, tailored for oral vaccination.
EU-OPENSCREEN ERIC: EU initiative supports research on future medical chemistry
Use EU-OPENSCREEN ERIC’s newly funded EU-OPENSCREEN-DRIVE project to advance your research now.
Experiments show that an “unknown” enzyme fights inflammation
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
Hoping to treat osteoarthritis using artificial cartilage tissue
A Norwegian-Swiss research team has succeeded in growing cartilage tissue cells using algae. Moreover, the new cells can reduce joint inflammation. This news gives hope for people suffering from arthrosis, also known as osteoarthritis.